glp 1 and ulcerative colitis The Potential for GLP-1s in the Treatment of Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
View the current Novi offer (official Novi page) What Is Novi and Who Operates It
Nausea is one of the most frequently reported side effects, affecting approximately 50% of patients taking GLP-1 medications, whilst vomiting occurs in about 15-25% of patients
In the SMR analysis, the primary outcomes were DR and different severity of DR
It wasn't that I just wasn't hungry anymore, but it felt like I couldn't swallow food anymore
K.HernandezA
Both compounds should be viewed as long-term or potentially lifelong therapies rather than short-term interventions
